News
05.22.2012
Trustees, donors, faculty, staff and UM and Miller School leadership celebrated and dedicated the Fred Havenick Intensive Care Unit at Sylvester Comprehensive Cancer Center on May 8.
05.01.2012
Fueled by the work of more than 21,000 volunteers, The Pap Corps: Champions for Cancer Research, presented its annual gift to the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine -- a check in the amount of $3.2 million.
05.01.2012
One day soon, the 50,000 Americans destined to be diagnosed with head and neck cancer annually could learn with a simple test that they could develop the deadly disease long before the first lesion appears in their mouth. If so, the breakthrough will have been enabled by the research of a Miller School otolaryngologist, the passions of a Georgia attorney and the office that united them.
05.01.2012
Stephen D. Nimer, M.D., the new director of the Sylvester Comprehensive Cancer Center, officially starts work this week.
05.01.2012
Dr. Stephen D. Nimer brings 30 years of pioneering clinical and research experience to the cancer center.
04.23.2012
A new analysis by a team of researchers at the Miller School’s Sylvester Comprehensive Cancer Center has found that Hispanic lung cancer patients seem to live longer than white or black patients.
04.20.2012
Howard Lessner, M.D., who became the first director of the University of Miami’s Comprehensive Cancer Center in 1972, passed away on April 18 at South Miami Hospital. He was 85.
04.19.2012
Scores of lung cancer experts from around the world gathered at the Miller School of Medicine April 16 for the 26th International Conference on Screening for Lung Cancer.
04.17.2012
Show your support for Sylvester by contacting Governor Rick Scott at 850-488-7146 or rick.scott@eog.myflorida.com.
04.03.2012
More than 3,200 walkers took part in the 12th Annual Pap Corps Walkathon at Florida Atlantic University in Boca Raton, enjoying one of the signature events of the all-volunteer group, which raises money exclusively for cancer research at Sylvester Comprehensive Cancer Center.
03.07.2012
Stephen D. Nimer, M.D., one of the world’s premier leukemia and stem cell transplant researchers and clinicians, has been named the new director of the Sylvester Comprehensive Cancer Center.
03.06.2012
A groundbreaking Miller School study funded by the National Cancer Institute’s Office of Cancer Survivorship has found all survivors of childhood cancer face a higher long-term risk of cardiovascular diseases and should be screened for a wide range of potential heart conditions.
03.06.2012
As a Miller School researcher in her first faculty appointment, Erin Kobetz, Ph.D., M.P.H., discovered a high rate of cervical cancer among the women in Miami's Little Haiti neighborhood and teamed up with communiity collaborators to eradicate the preventable disease.
03.01.2012
A new Miller School study has identified two cardiac biomarkers that could be early indicators of heart damage in childhood cancer survivors. The study, another major step in determining cardiac damage in childhood cancer patients, was led by Steven E. Lipshultz, M.D., professor and chair of pediatrics and executive associate dean for child health.
02.28.2012
More than 200 researchers attended the Miller Office of Research's Shared Resources Fair on February 17, which was followed by a Collaborative Research Exchange Forum (CREF) on drug discovery.
02.27.2012
The first patient in Florida to receive a novel vaccine for brain cancer, Cathy Hoffman-Booker is optimisitc about her participation in a clinical trial using a vaccine derived from her own brain tumor – a glioblastoma multiforme, the most common form of brain cancer.
02.17.2012
Institution hopes to raise $1.6 billion by the year 2016; $906 million already raised, as campaign gets under way with $100 million lead gift from Diabetes Research Institute Foundation.
02.16.2012
The proclamation recognizes the work The Pap Corps has done over the last 60 years to raise money for cancer research.
02.14.2012
Four UM researchers offered a glimpse of the exciting cancer research taking place at the Miller School at the 2012 Gastrointestinal Cancers Symposium, the largest meeting in the world dedicated to research and breakthroughs in gastrointestinal malignancies.
02.03.2012
The Miller Office of Research is sponsoring the third annual University-wide Shared Resources Fair on Friday, Feb. 17, 2012. The goal of the fair is to improve awareness of University resources with an eye toward promoting scientific collaboration.
01.26.2012
Accompanied by the Miller School's Joseph Rosenblatt, M.D., and Michael Lewis, MD., Dean Pascal J. Goldschmidt, M.D., joined Florida Governor Rick Scott last month on a trade mission to Israel aimed at attracting Israeli companies to Florida and fostering stronger ties between the Sunshine State and the Jewish state.
01.25.2012
Former Miami Dolphins wide receiver Mark “Super” Duper had a rough ride during the second annual Dolphins Cycling Challenge on November 5, 2011. He never dreamed that as he was riding his bicycle to raise money for Sylvester Comprehensive Cancer Center in memory of Dolphins great Jim “Mad Dog” Mandich, there was a cancerous tumor growing inside his own body.
01.24.2012
Thanks to a $2 million gift from businessman, philanthropist, and UM alumnus Alexander “Alex” Daly, UHealth-University of Miami Health System’s youngest cancer patients soon will receive outpatient care in a brand-new, state-of-the-art facility that caters to the unique needs of children.
01.24.2012
Keyvan Nouri, M.D., the Richard Helfman Professor of Dermatologic Surgery, director of Mohs Micrographic Surgery, Dermatology, and Laser Surgery, and chief of Dermatology Services, Sylvester Comprehensive Cancer Center, accepted the first Louis C. Skinner, Jr., M.D., Endowed Chair in Dermatology at a January 18 ceremony on the Miller School campus.
01.18.2012
A team of Miller School physician-scientists has demonstrated that an antagonist of growth hormone-releasing hormone (GHRH) has the ability to suppress the progression of late stage prostate cancer.